Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Original Research

Accepted on 14 Feb 2025

Developing a predictive model and uncovering immune influences on prognosis for brain metastasis from lung carcinomas

in Cancer Molecular Targets and Therapeutics

Bowen Wang
Mengjia Peng
Yan Li
Jinhang Gao
Tao Chang

Frontiers in Oncology

doi 10.3389/fonc.2025.1554242

Review

Published on 14 Feb 2025

Wnt/β-catenin signaling pathway: an attractive potential therapeutic target in osteosarcoma

in Cancer Molecular Targets and Therapeutics

Yi Ding
Qin Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1456959

166 views

Original Research

Published on 14 Feb 2025

Develop a prognostic and drug therapy efficacy prediction model for hepatocellular carcinoma based on telomere maintenance-associated genes

in Cancer Molecular Targets and Therapeutics

Jian-Hao Zheng
Ding Shi
Yun-Jie Chen
Jian-Ping Liu
Zheng Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1544173

114 views

Brief Research Report

Accepted on 13 Feb 2025

Mapping MAGE-A4 Expression in Solid Cancers for Targeted Therapies Running header: Mapping MAGE-A4 expression in solid cancers Authors

in Cancer Molecular Targets and Therapeutics

Christin Habigt
Sylvie Rottey
Iben Spanggaard
Juanita Lopez
Elena Garralda
Emiliano Calvo
Oliver Bechter
Jayesh Desai
Rachel Galot
Leena Gandhi

Frontiers in Oncology

doi 10.3389/fonc.2025.1484182

Retraction

Accepted on 12 Feb 2025

Retraction: Corrigendum: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/b-Catenin Signaling Pathway Activation

in Cancer Molecular Targets and Therapeutics

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2025.1575643

Retraction

Accepted on 12 Feb 2025

Retraction: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/β-Catenin Signaling Pathway Activation

in Cancer Molecular Targets and Therapeutics

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2025.1575634

Original Research

Accepted on 12 Feb 2025

Prognostic value of CA125 in diffuse large B-cell lymphoma

in Cancer Molecular Targets and Therapeutics

Xiaohong Xu
Jie Zhang
Yijing Jiang
Long Chen
Linyan Xu
Bojian Ge
Xiaobing Miao

Frontiers in Oncology

doi 10.3389/fonc.2025.1548399

Review

Published on 12 Feb 2025

Exploration of the quantitative-effectiveness association between acupuncture temporal parameters and chemotherapy-induced peripheral neuropathy in cancer patients: a dose-response meta-analysis of randomized controlled trials

in Cancer Molecular Targets and Therapeutics

Hao Tian
Qin Luo
Liuyang Huang
Guang Chen
Mingsheng Sun
Fanrong Liang

Frontiers in Oncology

doi 10.3389/fonc.2024.1527331

236 views

Original Research

Published on 12 Feb 2025

ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation

in Cancer Molecular Targets and Therapeutics

Jiaxing Zhang
Gang Wang
Jie Liu
Futian Tang
Song Wang
Yumin Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1513622

208 views

Review

Published on 12 Feb 2025

The role of ESRP1 in solid tumor development through the regulation of CD44 splicing and EMT processes

in Cancer Molecular Targets and Therapeutics

Lili Wang
Min Zhang
Ke Lei Zhao
Xiaohan Yuan
Houyu Zhao
Yanting Liu
Yinghua Ji
Ping Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1451130

133 views

Original Research

Accepted on 11 Feb 2025

The efficacy and safety of 225 Ac-PSMA-617 in metastatic castration-resistant prostate cancer

in Cancer Molecular Targets and Therapeutics

Jiao Ma
Yu Zhang
Jiangchu Yangqing
Guangfu Liu
Junzheng Wang
Chunyin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1516860

Review

Published on 11 Feb 2025

New options for targeting TRPV1 receptors for cancer treatment: odorous Chinese herbal medicine

in Cancer Molecular Targets and Therapeutics

Minghui Zhang
Zongao Wang
Shaojun Liu
Yuxuan Li
Yanting Gong
Min Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1488289

124 views

Review

Published on 11 Feb 2025

Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance

in Cancer Molecular Targets and Therapeutics

Caihong Li
Dongkai Cheng
Peng Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1542811

227 views

Editorial

Published on 11 Feb 2025

Editorial: Drug repurposing for cancer treatment: current and future directions

in Cancer Molecular Targets and Therapeutics

Marios Lampros
Nikolaos Vlachos
Georgios D. Lianos
Christina Bali
George A. Alexiou

Frontiers in Oncology

doi 10.3389/fonc.2025.1550672

215 views

Opinion

Accepted on 10 Feb 2025

Imaging, clinical, and histopathological challenges in diagnosing retroperitoneal extraskeletal osteosarcoma

in Cancer Molecular Targets and Therapeutics

Jiro Ichikawa
Tomonori Kawasaki
Kojiro Onohara
Masanori Wako
Naofumi Taniguchi
Satoshi Ochiai
Hirotaka Haro

Frontiers in Oncology

doi 10.3389/fonc.2025.1454055

Case Report

Published on 10 Feb 2025

A rare case of vision loss caused by leptomeningeal metastasis of lung adenocarcinoma: a case report and literature review

in Cancer Molecular Targets and Therapeutics

Zhihua Li
Jian Chu
Wennan Shen
Junnan Chen
Yuemei Dong
Manze Zhang
Nan Zhao
Wei Zhao
Haoran Zha
Ning Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1484383

193 views

Navigation group

Articles

Developing a predictive model and uncovering immune influences on prognosis for brain metastasis from lung carcinomas

Wnt/β-catenin signaling pathway: an attractive potential therapeutic target in osteosarcoma

Develop a prognostic and drug therapy efficacy prediction model for hepatocellular carcinoma based on telomere maintenance-associated genes

Mapping MAGE-A4 Expression in Solid Cancers for Targeted Therapies Running header: Mapping MAGE-A4 expression in solid cancers Authors

Retraction: Corrigendum: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/b-Catenin Signaling Pathway Activation

Retraction: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/β-Catenin Signaling Pathway Activation

Prognostic value of CA125 in diffuse large B-cell lymphoma

Exploration of the quantitative-effectiveness association between acupuncture temporal parameters and chemotherapy-induced peripheral neuropathy in cancer patients: a dose-response meta-analysis of randomized controlled trials

ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation

The role of ESRP1 in solid tumor development through the regulation of CD44 splicing and EMT processes

The efficacy and safety of 225 Ac-PSMA-617 in metastatic castration-resistant prostate cancer

New options for targeting TRPV1 receptors for cancer treatment: odorous Chinese herbal medicine

Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance

Editorial: Drug repurposing for cancer treatment: current and future directions

Imaging, clinical, and histopathological challenges in diagnosing retroperitoneal extraskeletal osteosarcoma

A rare case of vision loss caused by leptomeningeal metastasis of lung adenocarcinoma: a case report and literature review